Back to Search
Start Over
639 BASECAMP-1: Leveraging HLA loss of heterozygosity in solid tumors by NGS to identify patients with relapsed solid tumors for future CEA and MSLN logic-gated Tmod™ CAR T-cell therapy
639 BASECAMP-1: Leveraging HLA loss of heterozygosity in solid tumors by NGS to identify patients with relapsed solid tumors for future CEA and MSLN logic-gated Tmod™ CAR T-cell therapy
- Source :
- Regular and Young Investigator Award Abstracts.
- Publication Year :
- 2022
- Publisher :
- BMJ Publishing Group Ltd, 2022.
Details
- Database :
- OpenAIRE
- Journal :
- Regular and Young Investigator Award Abstracts
- Accession number :
- edsair.doi...........f6ae07ed46986b05129836d4c3d8ddad
- Full Text :
- https://doi.org/10.1136/jitc-2022-sitc2022.0639